See All Slides - tctmd.com

Slides

Presentation TCT 2012

Dedicated Bifurcation Stents: Minvasys Nile Program Update

Presenter: Roxana Mehran

October 22, 2012

Presentation TCT 2012

SUPPORT-1: A Prospective, Randomized Trial of a Lipoic Acid-Based Cytoprotectant in Patients Undergoing Elective PCI

Presenter: Mitchell Krucoff

October 22, 2012

Presentation TCT 2012

Allogenic Cells for Chronic Left Ventricular Dysfunction: The USA Experience and Beyond

Presenter: Emerson Perin

October 22, 2012

Presentation TCT 2012

TVT Goes Viral: New Valve Systems and Accessory Devices Will Transform the Future

Presenter: Eberhard Grube

October 22, 2012

Presentation TCT 2012

My Criteria for Selecting Transapical TAVR (vs. Transfemoral TAVR or Open Surgery)

Presenter: Rudiger Lange

October 22, 2012

Presentation TCT 2012

New Pacemakers After TAVR: Frequency, Predictors, Clinical Outcomes, and Guidelines on “When to Treat”

Presenter: Jeffrey Popma

October 22, 2012

Presentation TCT 2012

An Overview of TAVR Complications from a Meta-analysis Using VARC Definitions

Presenter: Philippe Genereux

October 22, 2012

Presentation TCT 2012

Improved Patient Screening, Meticulous Access and Closure Techniques, and Lower Profile Catheter Systems Can Reduce Major Vascular Complications to <5%: The Vancouver Experience

Presenter: John Webb

October 22, 2012

Presentation TCT 2012

TCT-106: BioInnovate Ireland: A Multidisciplinary Approach To Medical Device Innovation

Presenter: Mark Bruzzi

October 22, 2012

Presentation TCT 2012

Top 5 Ways to Educate and Improve the CAS Environment

Presenter: L. Nelson Hopkins

October 22, 2012

Advertisement

Slides

Dedicated Bifurcation Stents: Minvasys Nile Program Update

SUPPORT-1: A Prospective, Randomized Trial of a Lipoic Acid-Based Cytoprotectant in Patients Undergoing Elective PCI

Allogenic Cells for Chronic Left Ventricular Dysfunction: The USA Experience and Beyond

TVT Goes Viral: New Valve Systems and Accessory Devices Will Transform the Future

My Criteria for Selecting Transapical TAVR (vs. Transfemoral TAVR or Open Surgery)

New Pacemakers After TAVR: Frequency, Predictors, Clinical Outcomes, and Guidelines on “When to Treat”

An Overview of TAVR Complications from a Meta-analysis Using VARC Definitions

Improved Patient Screening, Meticulous Access and Closure Techniques, and Lower Profile Catheter Systems Can Reduce Major Vascular Complications to <5%: The Vancouver Experience

TCT-106: BioInnovate Ireland: A Multidisciplinary Approach To Medical Device Innovation

Top 5 Ways to Educate and Improve the CAS Environment

Search Slides

Advertisement

Advertisement

Slides

Search Slides

Sign Up for Our Newsletter

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content